Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1189-1191

  Cynamon, M H ^a   Klemens, S P ^a   Sharpe, C A ^a   Chase, S ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPEREZOLID; ISONIAZID; LINEZOLID; OXAZOLINE DERIVATIVE; PNU 100480; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; FEMALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032960636     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1189     Document Type: Article

References (15)

1. Ashtekar, D. R., R. Costa-Periera, T. Shrinivasan, R. Iyyer, N. Vishvanathan, and W. Rittel. 1991. Oxazolidinone, a new class of synthetic antituberculosis agent: in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis. Diagn. Microbiol. Infect. Dis. 14:465-471.
2. Barbachyn, M. R., S. J. Brickner, C. W. Ford, S. Glickman, K. D. Grega, S. K. Hendges, J. O. Kilburn, D. S. Toops, D. A. Ulanowicz, and G. E. Zurenko. 1995. Synthesis and structure-activity relationships of new tropone-substituted oxazolidinone antibacterial agents, abstr. F206, p. 149. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Barbachyn, M. R., D. K. Hutchinson, S. J. Brickner, M. H. Cynamon, J. O. Kilburn, S. P. Klemens, S. E. Glickman, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem. 39:680-685.
4. Bostic, G. D., M. B. Perri, L. A. Thai, and M. J. Zervos. 1998. Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multi-drug-resistant enterococci. Diagn. Microbiol. Infect. Dis. 30:109-112.
5. Eustice, D. C., G. M. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
6. Ford, C. W., J. C. Hamel, D. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey Jr., D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513.
7. Howard, M. R., I. J. Martin, M. J. Ackland, M. L. Sedlock, R. A. Anstadt, M. R. Barbachyn, S. J. Brickner, and D. K. Hutchinson. 1995. Preliminary pharmacokinetic and metabolic study of U-100480, a substituted oxazolidinone antibiotic, in the rat, abstr. F230, p. 153. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
9. Kirk, R. E. 1986. Experimental design: procedures for the behavioral science. Brooks-Cole Publishing Co., Belmont, Calif.
10. Koike, S. H. Miura, R. Nakamura, K. Chiba, and J. B. Moe. 1995. Drug safety studies with a novel oxazolidinone, U-100766, abstr. F224, p. 152. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Lin, A. H., R. W. Murray, T. J. Vidmar, and K. R. Marotti. 1997. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob. Agents Chemother. 41:2127-2131.
12. Slatter, J. G. Personal communication.
13. Vestal, A. L. 1969. Procedures for the isolation and identification of mycobacteria, p. 113-115. Public Health Service publication no. 1995. Laboratory Division, National Communicable Disease Center, Atlanta, Ga.
14. Wong, C. S., G. S. Palmer, and M. H. Cynamon. 1988. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid. J. Antimicrob. Chemother. 22:863-866.
15. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.